Skip to main content

Table 2 Baseline demographics, rates of the device-associated infections, and acquisition and incidence of MDROs in patients in the MICU during the study period

From: Real-world experience of how chlorhexidine bathing affects the acquisition and incidence of vancomycin-resistant enterococci (VRE) in a medical intensive care unit with VRE endemicity: a prospective interrupted time-series study

 

MICU

Pre-intervention

(26 weeks)

Intervention

(26 weeks)

p-value

No. of patients

259

242

 

Age, years, median (IQR),

74 (62–81)

73 (57–81)

0.146d

Male, n (%)

155 (59.8)

140 (57.9)

0.650e

APACHE II score, median (IQR)

18 (13–23)

24 (16–32)

< 0.001d

VRE rectal carriage on ICU admission, n (%)

17 (6.6)

11 (4.5)

0.326e

Receipt of surgery, n (%)

95 (36.7)

81 (33.5)

0.452e

Length of MICU stay, days, median (IQR)

13 (11–15)

13 (11–15)

0.723d

Length of hospital stay, days, median (IQR)

25 (17–49)

24 (14–45)

0.699d

In-hospital mortality, n (%)

98 (37.8)

77 (31.8)

0.158e

Device utilization ratioa

 Mechanical ventilator

0.50

0.63

< 0.001e

 Urinary catheter

0.97

0.93

0.226e

 Central venous catheter

0.64

0.63

0.927e

Device-related infectionsb

 CLA-BSI

1.25

1.28

0.983e

 CA-UTI, n (%)

1.95

2.40

0.781e

VRE acquisition rate by weekly active surveillance culturec

 Rectal VRE

20.17

9.34

< 0.001e

MDRO incidence rate by clinical culturesc

 VRE

5.11

1.60

0.006e

 MRSA

5.11

7.74

0.104e

 CRAB

11.02

11.20

0.850e

  1. CA-UTI, catheter-associated urinary tract infection; CLA-BSI, central line associated blood stream infection; ICU, intensive care unit; IQR, interquartile range; MDROs, multidrug-resistant organisms; MICU, medical intensive care unit; CRAB, carbapenem-resistant A. baumannii; MRSA, methicillin-resistant S. aureus; VAP, ventilator-associated pneumonia; VRE, vancomycin-resistant enterococci
  2. aDevice utilization ratio is calculated by dividing the number of device-days by the number of patient-days, unless otherwise stated
  3. bThe data are expressed as the total number of cases of device-associated infections per 1000 device-days, unless otherwise stated
  4. cThe data are expressed as the number of isolates per 1000 patient-days, unless otherwise stated
  5. dStudent’s t-test
  6. eChi-square test